CVS raises forecast for year, as first-quarter earnings top expectations

Health, Fitness & Food

A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York.
Shannon Stapleton | Reuters

CVS Health on Wednesday outpaced Wall Street’s expectations for first-quarter earnings and raised its guidance for the year, as it saw demand for at-home Covid tests, prescriptions and more.

The health-care company said it now expects adjusted earnings per share for 2022 to range from $8.20 to $8.40 compared with its previous forecast of between $8.10 to $8.30.

Shares were up more than 1% in premarket trading.

Here’s what the company reported for the three-month period ended March 31, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $2.22 adjusted vs. $2.15 expected
  • Revenue: $76.83 billion vs. $75.39 billion expected

The health-care company reported net income of $2.31 billion, or $1.74 per share, higher than the $2.22 billion, or $1.68 per share, a year earlier.

Excluding items, CVS earned $2.22 per share, more than the $2.15 per share expected by analysts surveyed by Refinitiv.

Revenue increased to $76.83 billion from $69.1 billion a year earlier. That topped/fell short of analysts’ expectations of $75.39 billion.

As of Tuesday’s close, shares of CVS are down about 7% so far this year, outperforming the 12% decline of the S&P 500. Shares closed Tuesday at $95.98, bringing the company’s market value to $126.04 billion.

This story is developing. Please check back for updates.

Products You May Like

Articles You May Like

Sweet Potato Casserole with Praline Topping
Smoked Salmon Cucumber Bites
How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS
My First Contortion Class Was Humbling — Here’s What It Taught Me

Leave a Reply

Your email address will not be published. Required fields are marked *